Delivery Order SPE2DB25D3306-SPE2DB25FUBFR
Award Date
4/2/25
Potential Completion Date
4/3/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,255.82, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has an ultimate completion date of July 26, 2024 and is a Firm Fixed Price Delivery Order contract. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,242.91, is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a medical product. The contract has an ultimate completion date of February 25, 2025 and is a Firm Fixed Price contract. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,975.60, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a medical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This federal contract award, valued at $3,704.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a medical product, and has a completion date of June 25, 2024. The contract is a delivery order, with a firm fixed-price pricing type. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,169.82 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a medical product. The contract has an ultimate completion date of October 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $1,150.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a medical product, with a performance period through March 14, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,552.01, is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has a period of performance through April 1, 2025 and utilizes a Firm Fixed Price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,363.20, is for the delivery of the drug XULANE 150-35 MCG/DAY PATCH 3S. The contract is a Firm Fixed Price Delivery Order with a completion date of May 30, 2024. There was no set-aside designation for this award. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $13,904.80, is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. This is a firm fixed-price delivery order contract with a period of performance through December 17, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award, valued at $3,014.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a medical product. The contract has a firm fixed price and the ultimate completion date is March 26, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...